AstraZeneca COVID-19 antibody drug offers 83% protection over six months

The Anglo-Swedish company also said that patients with mild-to-moderate COVID-19 showed a higher dose of the drug cut the risk of symptoms worsening by 88% when given within three days.

Health workers provide vaccination cards to residents recently inoculated with AstraZeneca vaccine against the coronavirus disease (COVID-19), inside a bus converted into a mobile vaccination site in Taguig, Metro Manila, Philippines, May 21, 2021

(photo credit: REUTERS/LISA MARIE DAVID)

ByREUTERS

NOVEMBER 18, 2021 10:02

RECOMMENDED STORIES

Palestinian Hamas terrorists keep guard on the day Hamas handed over deceased hostages in Khan Younis in the southern Gaza Strip February 20, 2025.

Admitting defeat? Why Hamas officials say the terror group 'lost control' of Gaza

JULY 7, 2025

Members of Hamas with the backdrop of the Gaza Strip, amid reports that Hamas has lost control of much of its territory.

'Security situation has collapsed': Hamas has lost 80% of its control over Gaza Strip

JULY 7, 2025

Reporter's Notebook: 'Post' meets with top Hebron sheikh who wants to pull out of PA

JULY 6, 2025

IDF Maj.-Gen. Aviad Dagan entering a fighter jet; illustrative.

IDF cyber chief, retired Iran strategy head piloted fighter jets striking Iran

JULY 6, 2025

Hot Opinion

War doesn't end on the battlefield: Israel must better support veterans with PTSD

ByJPOST EDITORIAL

Israel's midnight strategist: How IDF chief Eyal Zamir rewired the doctrine on Iran

ByZVIKA KLEIN, YONAH JEREMY BOB

As thousands stay away, Ethiopian Israelis pay a heavy price in Gaza war

ByYAAKOV KATZ

Can Donald Trump win a Nobel Peace Prize?

ByAMOTZ ASA-EL